Syndexa Pharmaceuticals Corp., a Cambridge, Mass.-based metabolic drug discovery company, has raised $15 million in venture capital funding. The round was led by Yalcin Ayalsi, founder of Hitite Microwave Corp. www.syndexa.com
Syndexa Pharmaceuticals Corp., a Cambridge, Mass.-based metabolic drug discovery company, has raised $15 million in venture capital funding. The round was led by Yalcin Ayalsi, founder of Hitite Microwave Corp. www.syndexa.com
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.